Engaging anti-inflammatory mechanisms and triggering inflammatory effector apoptosis during Familial Mediterranean Fever attack

Inflammation Research

Volumn 57, Issue 2, 2008, Pages 65-74

  Davtyan, T K ^a   Hakobyan, G S ^b   Avetisyan, S A ^b   Harutyunyan, V A ^b  

^a Armenicum Research Centre Yerevan   (Armenia)

^b YEREVAN STATE MEDICAL UNIVERSITY   (Armenia)

Author keywords

Cytokine synthesis polarization; Endotoxin tolerance; Familial Mediterranean Fever; Monocyte apoptosis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; COLCHICINE; CYTOKINE; DEXTRIN; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 4; IODINE; LITHIUM; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APOPTOSIS; ARTICLE; BLOOD CELL; CONTROLLED STUDY; CROSS TOLERANCE; CYTOKINE PRODUCTION; DOWN REGULATION; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; MALE; MONOCYTE; NEUTROPHIL; REMISSION;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CYTOKINES; ENDOTOXINS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; REMISSION INDUCTION;

EID: 39749160353     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-7074-6     Document Type: Article

References (54)

1. Orbach H, Ben-Chetrit E. Familial Mediterranean fever. Minerva Med 2001; 92: 421-30.
2. Sarkisian T, Ajrapetyan H, Shahsuvaryan G. Molecular study of FMF patients in Armenia. Curr Drug Targets 2005; 4(3): 85-98.
3. International FMF Consortium. Ancient missense mutation in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797-807.
4. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31.
5. Centola M, Wood G, Frucht DM, Galon J, Aringer M, Farrell C et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000; 95: 3223-31.
6. Staub E, Dahl E, Rosenthal A. The DAPIN family: a novel domain links apoptotic and interferon response proteins. Trends Biochem Sci 2001; 26: 83-5.
7. Richards N, Schaner P, Diaz A, Stuckey J, Shelden E, Wadhwa A et al. Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chem 2001; 276: 39320-29.
8. Stehlik C, Fiorentino L, Dorfleutner A, Bruey JM, Ariza EM, Sagara J et al. The PAAD/PYRIN family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways. J Exp Med 2002; 196: 1605-15.
9. Pras M, Bronshpigel N, Zemer D, Gafni J. Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups. Johns Hopkins Med J 1982; 150: 22-6.
10. Delibas A, Oner A, Balci B, Demircin G, Bulbul M, Bek K et al. Genetic risk factors of amyloidogenesis in familial Mediterranean fever. Am J Nephrol 2005; 25(5): 434-40.
11. Ben-Chetrit E, Levy M. Enigmas in familial Mediterranean fever (FMF). Clin Exp Rheumatol 2001; 19(24): S1-5.
12. Cazeneuve C, Hovannesyan Z, Genevieve D, Hayrapetyan H, Papin S, Girodon-Boulandet E et al. Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. Arthritis Rheum 2003; 48(8): 2324-31.
13. Bagci S, Toy B, Tuzun A, Ates Y, Aslan M, Inal A et al. Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 2004; 23: 333-7.
14. Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L et al. Does immune activation continue during attack-free period in familial Mediterranean fever? Clin Exp Immunol 2004; 138: 526-33.
15. Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatol 2006; 45: 746-50.
16. Schaner PE, Gumucio DL. Familial Mediterranean fever in the post-genomic era: how an ancient disease is providing new insights into inflammatory pathways. Curr Drug Targets 2005; 4: 67-76.
17. Wells CA, Ravasi T, Hume DA. Inflammation suppressor genes: please switch out all the lights. J Leukoc Biol 2005; 78: 9-13.
18. Han J, Ulevitch RJ. Limiting inflammatory responses during activation of innate immunity. Nature Immunol 2005; 6: 1182-90.
19. Serhan CN, Savil J. Resolution of inflammation: the beginning programs the end. Nature Immunol 2005; 6: 1191-7.
20. Liew FY, Damo X, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nature Rev Immunol 2005; 5: 446-58.
21. Medvedev AE, Sabroe I, Hasday JD, Vogel SN. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res 2006; 12: 133-50.
22. Davtyan TK, Hakobyan GS, Avetisyan SA, Mkrtchyan NR. Impaired endotoxine tolerance induction in patients with familial Mediterranean fever. Pathobiology 2006; 73: 26-39.
23. Procheray F, Viaud S, RimaniolL A-C, Leone C, Samah B, Dereuddre-Bosquet N, Dormont D, Gras G. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 142, 2005, 481-9.
24. Ozen S, Uckan D, Baskin D Besbas N, Okur H, Saatci U, Bakkaloglu A. Increased neutrophil apoptosis during attacks of familial Mediterranean fever. Clin Exp Rheum 2001; 19(24): S68-S71.
25. Davtyan TK, Mkrtchyan NR, Manukyan HM, Avetisyan SA. Dexamethasone, colchicine and iodine-lithium-a-dextrin act differentially on the oxidative burst and endotoxin tolerance induction in vitro in patients with Behcet's disease. Int Immunopharmacol 2006; 6: 396-407.
26. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T. Criteria for a diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-85.
27. IIin AI. Armenicum - a new drug with antiviral and antibacterial properties. In: Gabrielyan ES, edited. Armenicum: Experimantal studies. Yerevan: Gitutyun, Nat. Acad. Sci Armenia, 2000; 7-15.
28. Davtyan TK, Manukyan HM, Hakobyan GS, Mkrtchyan NR, Avetisyan SA, Galoyan AA. Hypothalamic proline-rich polypeptide is an oxidative burst regulator. Neurochem Res 2005; 30: 297-309.
29. Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 2002; 61: 79-81.
30. Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, Kastner DL. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA 2006; 103; 9982-7.
31. Schaner P, Richards N, Wadhawa A, Aksentijevich I, Kastner DL, Tucker P et al. Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states. Nat Genet 2001; 27: 318-21.
32. Ross JJ. Goats, germs, and fever: Are the pyrin mutations responsible for familial Mediterranean fever protective against Brucellosis? Med Hypotheses 2007; 68: 499-501.
33. Chae JJ, Komarov HD, Cheng J, Wood G, Raben N, Liu PP et al. Targeted disruption of pyrin the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003; 7: 591-604.
34. Li CH, Wang JH, Redmond HP. Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation. J Leukoc Biol 2006; 79: 867-75.
35. Molad Y, Fridenberg A, Bloch k, Langevitz P, Mukamel M, Sulkes J et al. Neutrophil adhesion molecule expression in familial Mediterranean fever; discordance between the intravascular regulation of 2-integrin and L-selectin expression in acute attack. J Investig Med 2004: 50: 58-61.
36. Miggin SM, Palsson-McDermott E, Dunne A, Jefferies C, Pinteaux E, Banahan K et al. NF-κB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1. Proc Natl Acad Sci USA 2007; 104; 3372-7.
37. Stehlik C, Reed JC. The pyrin connection: novel players in innate immunity and inflammation. J Exp Med 2004; 200: 551-8.
38. Tschopp J, Martinon F, Burns K. NALPS; novel protein family involved in inflammation. Nature Rev Mol Cell Biol 2003; 4: 95-104.
39. Baykal Y, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol. 2003; 22: 99-101.
40. Schattner A, Gurevitz A, Zemer D, Hahn T. Induced TNF production in vitro as a test for familial Mediterranean fever. QJM 1996; 89(3): 205-10.
41. Gang N, Drenth JP, Langevitz P, Zimer D, Brezniak N, Pras M et al. Activation of the cytokine network in familial Mediterranean fever. J Rheumatol 1999; 26: 890-7.
42. Aypar E, Ozen S, Okur H, Kutluk T, Besbas N, Bakkaloglu A. Th1 polarization in familial Mediterranean fever. J Rheumatol 2003; 30: 2011-3.
43. Simsek I, Pay S, Pekel A, Dinc A, Musabak U, Erdem H et al. Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int. 2007; DOI: 10.1007/s00296-006-0301- 6.
44. Adib-Conquy M, Cavalion JM. Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression. J Biol Chem 2002; 277: 27927-34.
45. Avetisyan SA, Hakobyan GS, Davtyan TK. Modulation of endotoxin-induced respiratory splash of granulocytes and monocytes in patients with familial Mediterranean fever by iodine-lithium-α-dextrin and sodium thiosulfate. Patol Fiziol Eksp Ter. 2006; 1: 11-3.
46. Davtyan TK, Avetisyan SA, Hakobyan GS, Haruthunyan VM. A respiratory splash of monocytes and neutrophils in Familial Mediterranean fever. Ter Arkh 2005; 77: 39-43.
47. Stehlik C, Lee SH, Dorfleutner A, Stassinopoulos A, Sagara J, Reed JC. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J Immunol 2003; 171: 6154-63.
48. Masumoto J, Taniguchi S, Nakayama J, Shiohara M, Hidaka E, Katsuyama T et al. Expression of apoptosis-associated speck-like protein containing a caspase recruitment domain, a pyrin N-terminal homology domain-containing protein, in normal human tissues. J Histochem Cytochem 2001; 49(10): 1269-75.
49. Luster AD, Alon R, von Andrian UH. Immune cell migration and inflammation: present and future therapeutic targets. Nature Immunol 2005; 6: 1182-90.
50. Kalyoncu M, Celiker Acar B, Cakar N, Bakkaloglu A, Ozturk S, Dereli E et al. Are carriers for MEVF mutations "healty"? Clin Exp Rheumatol 2006; 24: S120-2.
51. Grimaldi MP, Candore G, Vasto S, Caruso M, Caimi G, Hoffmann E et al. Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population. J Leukoc Biol 2006; 79(3): 611-5.
52. Arra M, Emanuele E, Martinelli V, Minoretti P, Bertona M, Geroldi D. The M694V variant of the familial Mediterranean fever gene is associated with sporadic early-onset Alzheimer's disease in an Italian population sample. Dement Geriatr Cogn Disord 2007; 23(1): 55-9.
53. Rabinovich E, Livneh A, Langevitz P, Brezniak N, Shinar E, Pras M et al. Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 2005; 64: 1009-14.
54. Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH et al. Molecular circuits of resolution: formation and actions resolvins and protectins. J Immunol 2005; 174: 4345-55.